Press Releases Cynata Therapeutics Limited

Equities

CYP

AU000000CYP7

Market Closed - Australian S.E. Other stock markets 02:10:16 2024-06-04 am EDT			5-day change	1st Jan Change
0.33 ^AUD	+3.12%		+11.86%	+164.00%

Apr. 08	Cynata Therapeutics Limited Completes Patient Enrolment in CYP-006TK Diabetic Foot Ulcer Clinical Trial	CI
Apr. 08	Cynata Therapeutics Concludes Patient Enrolment in Diabetic Foot Ulcer Wound Dressing Product Trial	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Acute Respiratory Distress Syndrome Pipeline \| Clinical Trials and Key Companies	Nov. 08	AQ
Cynata Therapeutics : 23 April 2023 Capital Raising Presentation	23-05-11	PU
Cynata Therapeutics : Updated Investor Presentation	22-03-07	PU
Cynata Therapeutics : AGM Presentations	21-11-15	PU
Ethics Approval for Cynata’s Clinical Trial in Diabetic Foot Ulcers	21-06-30	GL
Cynata Therapeutics : signs Licence Agreement with TekCyte to advance Clinical Trial in Diabetic Foot Ulcers	21-06-03	AQ
Cynata Therapeutics : First Patient Enrolled in Cynata’s MEND Clinical Trial	21-05-24	AQ
Cynata Therapeutics : Expands MEND clinical trial in COVID-19 and Respiratory Failure	21-03-29	AQ
Cynata Therapeutics : New Preclinical Study to Investigate the High Potency of Cymerus™ MSCs	21-03-02	AQ
Cynata Therapeutics : Advances Planned Clinical Trial in Diabetic Foot Ulcers in MoU With TekCyte	21-03-01	AQ
Cynata Therapeutics : Secures $15m Placement Led By $10m from Healthcare Investor BioScience Managers to Expand Development Pipeline	20-12-11	AQ
Cynata Therapeutics : Phase 3 Osteoarthritis Clinical Trial Commences	20-11-11	AQ
Cynata Therapeutics : Cymerus MSCs Demonstrate Efficacy in Preclinical Lung Disease Study	20-09-08	AQ
Cynata Therapeutics : Preclinical Study Showing Beneficial Effects of Cymerus™ MSCs in Acute Respiratory Distress Syndrome Accepted for Publication in Leading Peer-Reviewed Journal	20-04-17	AQ
Cynata Therapeutics : UK Regulatory Authority Approves Cynata’s Phase 2 Clinical Trial in Critical Limb Ischaemia	20-01-14	AQ
Cynata Therapeutics : CYP Files Application to Commence Phase 2 CLI Clinical Trial	19-11-24	PU
Cynata Completes Clinical Study Report for Phase 1 Trial of CYP-001 in GvHD	18-12-18	GL
NHMRC to Fund Major Phase 2 Clinical Trial of Cynata’s Cymerus™ MSCs in Patients with Osteoarthritis	18-12-13	GL
Cynata Therapeutics : 18.11.01.Cynata Outlook and Investor Presentation	18-10-31	PU
Cynata Therapeutics : 18.10.26.Appendix 3Y-Dr Paul Wotton	18-10-25	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Cynata Therapeutics Limited

Equities

CYP

AU000000CYP7

Press Releases

Filters